Economics of Atypical Antipsychotics in Bipolar DisorderA Review of the Literature

被引：0
|
作者：
Rachael L. Fleurence
Julia M. Dixon
Dennis A. Revicki
机构：
[1] Health Care Analytics Group,United BioSource Corporation
来源：
CNS Drugs | 2006年 / 20卷
关键词：
Bipolar Disorder; Haloperidol; Risperidone; Olanzapine; Quetiapine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Economic evaluations are increasingly being used by policy makers to evaluate the relative costs and benefits of healthcare interventions. These analyses provide economic and clinical evidence to decision makers seeking to make recommendations on treatment alternatives for patients. This article describes the economic evidence on the atypical antipsychotics currently approved for the treatment of bipolar disorder.
引用
收藏
页码：591 / 599
页数：8
相关论文
共 50 条
  • [41] Efficacy and Safety of Atypical Antipsychotics in Bipolar Disorder With Comorbid Substance Dependence: A Systematic Review
    Sepede, Gianna
    Lorusso, Marco
    Spano, Maria Chiara
    Di Nanno, Piero
    Di Iorio, Giuseppe
    Di Giannantonio, Massimo
    CLINICAL NEUROPHARMACOLOGY, 2018, 41 (05) : 181 - 191
  • [42] Drug metabolism and atypical antipsychotics
    Prior, TI
    Chue, PS
    Tibbo, P
    Baker, GB
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1999, 9 (04) : 301 - 309
  • [43] Atypical antipsychotics in bipolar depression: Potential mechanisms of action
    Yatham, LN
    Goldstein, JM
    Vieta, E
    Bowden, CL
    Grunze, H
    Post, RM
    Suppes, T
    Calabrese, JR
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 : 40 - 48
  • [44] Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients
    Torrent, Carla
    Martinez-Aran, Anabel
    Daban, Claire
    Amann, Benedikt
    Balanza-Martinez, Vicente
    del Mar Bonnin, Caterina
    Cruz, Nuria
    Franco, Carolina
    Tabares-Seisdedos, Rafael
    Vieta, Eduard
    COMPREHENSIVE PSYCHIATRY, 2011, 52 (06) : 613 - 622
  • [45] The role of atypical antipsychotics in bipolar depression and anxiety disorders
    McIntyre, R
    Katzman, M
    BIPOLAR DISORDERS, 2003, 5 : 20 - 35
  • [46] Atypical antipsychotics related metabolic syndrome in bipolar patients
    Yumru, Mehmet
    Savas, Haluk A.
    Kurt, Erhan
    Kaya, M. Cemal
    Selek, Salih
    Savas, Esen
    Oral, E. Timucin
    Atagun, Ilhan
    JOURNAL OF AFFECTIVE DISORDERS, 2007, 98 (03) : 247 - 252
  • [47] Long-Term Treatment with Atypical Antipsychotics and the Risk of Weight GainA Literature Analysis
    Salvatore Gentile
    Drug Safety, 2006, 29 : 303 - 319
  • [48] Atypical antipsychotics lower TD incidence than conventional
    Reactions Weekly, 2004, 994 (1) : 4 - 4
  • [49] DO ATYPICAL ANTIPSYCHOTICS PROMOTE NEUROGENESIS AS A CLASS EFFECT?
    Agius, Mark
    Nandra, Karandeep Singh
    PSYCHIATRIA DANUBINA, 2012, 24 : S191 - S193
  • [50] Indications of atypical antipsychotics in the elderly
    McKean, Andrew
    Monasterio, Erik
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (01) : 5 - 7
12345